Journal of Cancer Prevention

eISSN 2288-3657
pISSN 2288-3649

Download original image

Fig. 3. Mechanisms and examples of TGF-β signaling inhibitors being explored in clinical trials. mAb, monoclonal antibody; TGF-β RI, TGF-β receptor type I; TGF-β RII, TGF-β receptor type II.
J Cancer Prev 2020;25:213~222 https://doi.org/10.15430/JCP.2020.25.4.213
© J Cancer Prev
Copyright © Korean Society of Cancer Prevention. All Rights Reserved. / Powered by INFOrang Co., Ltd